Release Summary

Sunovion announced multiple data analyses from two Phase 3 studies demonstrating that UTIBRON NEOHALER (indacaterol/glycopyrrolate) inhalation powder showing improvement in lung function and HRQL.

Sunovion Pharmaceuticals Inc.